Radiopharmaceuticals for Advanced Prostate Cancer

There are more therapies available for advanced prostate cancer than ever before providing people with advanced prostate cancer with more options and more hope. This video discusses PSMA-targeted therapy, or lutetium Lu 177 vipivotide tetraxetan, for advanced prostate cancer. Updates are provided by Mayo Clinic prostate cancer experts, Dan Childs, M.D., medical oncologist, Jacob Orme, M.D., Ph.D, medical oncologist, and Geoffrey Johnson, M.D., Ph.D., radiologist and nuclear medicine specialist.

Watch the video and learn more about advanced prostate cancer and PSMA-targeted therapy at mayoclinic.com/diseases-conditions/metastatic-prostate-cancer.

For more information about advanced prostate cancer, watch our video, About Advanced Prostate Cancer and Treatment Advancements: https://www.youtube.com/watch?v=M2k7OZsR5Z8

Chapter timestamps:
0:00 Hope for Advanced Prostate Cancer
0:22 What is Advanced Prostate Cancer
0:33 Treatment Approach for Metastatic Disease
0:52 Advanced Prostate Cancer Treatment Overview
1:06 Radiopharmaceuticals for Advanced Prostate Cancer
1:15 How lutetium Lu 177 vipivotide tetraxetan Works
2:04 Minimizing Side Effects with PSMA-targeted Therapy
2:57 Comprehensive Radiopharmaceutical Centers of Excellence
3:17 Advanced Prostate Cancer Care at Mayo Clinic

From Mayo Clinic to your inbox, sign-up for free: https://mayocl.in/3e71zfi

Visit Mayo Clinic: https://mayocl.in/2COVmlm

Like Mayo Clinic on Facebook: https://www.facebook.com/mayoclinic/
Follow Mayo Clinic on Instagram: https://www.instagram.com/mayoclinic/
Follow Mayo Clinic on X, formerly Twitter: https://x.com/MayoClinic
Follow Mayo Clinic on Threads: https://www.threads.net/@mayoclinic

Видео Radiopharmaceuticals for Advanced Prostate Cancer канала Mayo Clinic